Background Male breast cancer is a rare malignancy with a strong hereditary component. However, the prevalence and spectrum of germline pathogenic variants (PVs) in Chinese male breast cancer patients remain largely unknown, and the prognostic impact of PV status has not been elucidat...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.